PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Por um escritor misterioso
Descrição
Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
PDF) Statins, Fibrates and Myopathy: Pathophysiological Mechanism, Risk Factors and Laboratory Markers
Novel potassium binders: a clinical update
Dyslipidaemia in type 2 diabetes: cardiovascular risk assessment and management
PDF) Statin-induced myopathy: A review and update
Bile Acid Sequestrants for Hypercholesterolemia Treatment Using Sustainable Biopolymers: Recent Advances and Future Perspectives
Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?, Intensive Care Medicine Experimental
Myopathy with statin-fibrate combination therapy: clinical considerations - Document - Gale OneFile: Health and Medicine
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review
PDF) Narrative Review: Statin-Related Myopathy
de
por adulto (o preço varia de acordo com o tamanho do grupo)
/i.s3.glbimg.com/v1/AUTH_08fbf48bc0524877943fe86e43087e7a/internal_photos/bs/2021/W/9/bVE25CQ0W82KJWGSrW4w/simulacao-ifooddelivery.png)
